InvestSMART

Suda Pharmaceuticals Ltd (ASX: SUD) - Announcements

- Current share price for SUD : $0.048

ASX company news and announcements for Suda Pharmaceuticals Ltd (SUD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Suda Pharmaceuticals Ltd (SUD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Suda Pharmaceuticals Ltd (SUD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Suda Pharmaceuticals Ltd (SUD)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Corporate Presentation 27 Aug 2019 11:58AM $0.004 $0.048 risen by 1,100%
- New Project Director For Anagrelide Project 14 Aug 2019 8:17AM $0.005 $0.048 risen by 860%
- ArTiMist Appeal Lodged With TGA 9 Aug 2019 9:09AM $0.004 $0.048 risen by 1,100%
- Government Initiatives To Boost Medical Marijuana Industry 7 Aug 2019 8:20AM $0.004 $0.048 risen by 1,100%
- ZolpiMist Clinical Results Published 6 Aug 2019 12:27PM $0.004 $0.048 risen by 1,100%
- Appendix 4C - quarterly 31 Jul 2019 12:07PM $0.005 $0.048 risen by 966.67%
- Operational Update 25 Jul 2019 8:25AM $0.004 $0.048 risen by 1,100%
- European Anagrelide Cancer Patent 22 Jul 2019 8:19AM $0.003 $0.048 risen by 1,500%
- ArTiMist Regulatory Update 18 Jul 2019 8:28AM $0.003 $0.048 risen by 1,500%
- Top 20 Option Holders 10 Jul 2019 12:09PM $0.003 $0.048 risen by 1,500%
- Top 20 securityholders 3 Jul 2019 2:19PM $0.003 $0.048 risen by 1,500%
- Change of Director's Interest Notice (x2) 28 Jun 2019 12:32PM $0.004 $0.048 risen by 1,100%
- Rights Issue and Placement Completed and Appendix 3B 28 Jun 2019 12:09PM $0.005 $0.048 risen by 966.67%
- Supplementary Prospectus 27 Jun 2019 4:15PM $0.004 $0.048 risen by 1,100%
- Rights Issue Closes Significantly Oversubscribed 26 Jun 2019 8:20AM $0.004 $0.048 risen by 1,100%
- Rights Commence Trading 5 Jun 2019 1:09PM $0.006 $0.048 risen by 772.73%
- SUDA SIgns Binding Term Sheet With Cann Pharmaceutical 5 Jun 2019 9:28AM $0.005 $0.048 risen by 860%
- SUDA Expands Business Development Team 4 Jun 2019 12:47PM $0.005 $0.048 risen by 966.67%
- Corporate Presentation June 2019 4 Jun 2019 12:17PM $0.005 $0.048 risen by 966.67%
- Letter To Optionholders 3 Jun 2019 9:11AM $0.006 $0.048 risen by 700%
- Letter To Eligible Shareholders 3 Jun 2019 9:10AM $0.006 $0.048 risen by 700%
- Letter To Ineligible Shareholders 3 Jun 2019 9:09AM $0.006 $0.048 risen by 700%
- Appendix 3B 3 Jun 2019 9:08AM $0.006 $0.048 risen by 700%
- Prospectus For Renounceable Pro Rata Offer 3 Jun 2019 9:06AM $0.006 $0.048 risen by 700%
- Rights Issue To Raise Up To $3.44 Million 3 Jun 2019 9:03AM $0.006 $0.048 risen by 700%

151 - 175 of 445 results

Page 7 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.